TMO

Thermo Fisher Scientific Inc

696.97

Oct 30 • 3:59 PM ET -12.21 (-1.72%)

697.00

Aftermarket • 4:01 PM ET +0.03 (0.00%)

Healthcare Diagnostics & Research USA Mega NYSE

Peers: DHR A WAT IQV RVTY MTD ICLR ILMN BIO LH

| Held by: VTI VOO IVV SPY VTV XLV VHT SPYM IWD PVAL

Scroll to Statements

Index	S&P 500
Market Cap	257.70B
Enterprise Value	293.14B
Income	7.07B
Sales	47.35B
Book/sh	142.47
Cash/sh	16.39
Dividend Est.	1.86 (0.27%)
Dividend TTM	1.84 (0.26%)
Dividend Ex-Date	Sep 15, 2026
Dividend Gr. 3/5Y	12.75% 14.34%
Payout	9.70%
Employees	125000
IPO	Mar 17, 1980

P/E	36.77
Forward P/E	25.13
PEG	2.46
P/S	5.44
P/B	4.89
P/C	42.52
P/FCF	33.93
EV/EBITDA	23.91
EV/Sales	6.19
Quick Ratio	1.41
Current Ratio	1.81
Debt/Eq	0.76
LT Debt/Eq	0.71
Option/Short	Yes / Yes

EPS (ttm)	18.96
EPS next Y	27.73
EPS next Q	7.14
EPS this Y	10.55%
EPS next Y	9.69%
EPS next 5Y	10.20%
EPS past 3/5Y	0.18% 2.11%
Sales past 3/5Y	-0.27% 6.70%
EPS Y/Y TTM	9.59%
Sales Y/Y TTM	8.27%
EPS Q/Q	8.54%
Sales Q/Q	9.13%
Earnings	Oct 21 BMO
EPS/Sales Surpr.	4.32% 1.54%

Insider Own	0.26%
Insider Trans	-9.67%
Inst Own	93.64%
Inst Trans	-0.32%
ROA	6.52%
ROE	13.40%
ROIC	7.55%
Gross Margin	39.50%
Oper. Margin	19.33%
Profit Margin	14.94%
SMA20	2.57%
SMA50	6.47%
SMA200	26.41%
Trades

Shs Outstand	369.75M
Shs Float	368.79M
Short Float	1.33%
Short Ratio	2.33
Short Interest	4.89M
52W High	711.85 -2.09%
52W Low	435.27 60.12%
Volatility	2.43% 3.19%
ATR (14)	19.68
RSI (14)	59.14
Beta	0.85
Rel Volume	0.99
Avg Volume	2.09M
Volume	2,077,167

Perf Week	3.44%
Perf Month	6.81%
Perf Quarter	21.42%
Perf Half Y	48.54%
Perf YTD	20.28%
Perf Year	25.31%
Perf 3Y	60.55%
Perf 5Y	10.09%
Perf 10Y	373.46%
Recom	1.53
Target Price	761.72
Prev Close	709.18
Price	696.97
Change %	-1.72%

Consensus

Buy

Avg. Price Target

$761.72

Implied Upside

+9.3%

Analysts15incl. previous ratings

Rating Distribution11 Buy · 4 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 09, 2026	Upgrade	UUBS	Neutral → Buy	$730	+4.7%
Sep 03, 2026	Initiated	CCLSA	Outperform	$748	+7.3%
Jun 26, 2026	Resumed	BBernstein	Mkt Perform	$520	-25.4%
Jun 11, 2026	Initiated	PPiper Sandler	Neutral	$510	-26.8%
Jun 03, 2026	Downgrade	HHSBC Securities	Buy → Hold	$540	-22.5%
Jun 02, 2026	Resumed	WWolfe Research	Outperform	$535	-23.2%
May 15, 2026	Resumed	RRBC Capital Mkts	Sector Perform	$490	-29.7%
Mar 27, 2026	Initiated	DDZ Bank	Buy	$610	-12.5%
Dec 11, 2025	Upgrade	CCitigroup	Neutral → Buy	$660	-5.3%
Dec 09, 2025	Initiated	GGoldman	Buy	$685	-1.7%
Dec 08, 2025	Upgrade	KKeyBanc Capital Markets	Sector Weight → Overweight	$750	+7.6%
Dec 02, 2025	Resumed	MMorgan Stanley	Overweight	$670	-3.9%
Dec 01, 2025	Upgrade	HHSBC Securities	Hold → Buy	$670	-3.9%
Sep 11, 2025	Upgrade	BBarclays	Equal Weight → Overweight	$550	-21.1%
Aug 19, 2025	Initiated	WWilliam Blair	Outperform
Jul 24, 2025	Downgrade	HHSBC Securities	Buy → Hold	$510	-26.8%
Jul 11, 2025	Upgrade	BScotiabank	Sector Perform → Sector Outperform	$590	-15.3%
Jul 09, 2025	Downgrade	UUBS	Buy → Neutral	$460	-34.0%
Jan 10, 2025	Upgrade	BBernstein	Mkt Perform → Outperform	$630	-9.6%
Dec 23, 2024	Initiated	BScotiabank	Sector Perform

Oct-27-26 03:09PM	Top Research Reports for Alphabet, ExxonMobil & Toyota Motor (Zacks)
Oct-23-26 09:00AM	Qiagen agrees to private equity takeover (MedTech Dive)
Oct-21-26 04:59PM	7 healthcare stocks that stand out as investors pay up for the sector (MarketWatch)
04:08PM	Medical Giants Thermo Fisher, Danaher Reverse Higher - What Investors Are Seeing (Investor's Business Daily)
09:55AM	Thermo Fisher Scientific reported adjusted earnings of $6.68 per share, up 15% (Quartz)
09:51AM	Loading…
09:51AM	Thermo Fisher Scientific Reports 9% Revenue Growth as Third-Quarter Earnings Beat Estimates (InvestorsHub)
09:04AM	Thermo Fisher posts higher third-quarter revenue and earnings as margins improve (Proactive)
09:00AM	Thermo Fisher Extends Its Beat-And-Raise Run As Organic Growth Hits 6%, But Tariff Refunds And A Flat Q4 Guide Temper The Upside (Earnings Whispers)
06:41AM	Thermo Fisher beats profit, revenue expectations in Q3 (Investing.com)
06:08AM	Thermo Fisher: Q3 Earnings Snapshot (Associated Press)
06:00AM	Thermo Fisher Scientific Reports Third Quarter 2026 Results (Business Wire)
04:43AM	Meta and Tesla headline Wednesday's earnings slate (MarketWatch)
03:37AM	Stock Market Today: Dow set to pause as S&P 500, Nasdaq to rise after SpaceX results with Meta, Tesla earnings on tap (MarketWatch)
Oct-15-26 03:36PM	Healthcare Stocks Are on a Tear. Gilead and AbbVie Are Heading for Record Highs. (Barrons.com)
Oct-07-26 03:30PM	Quantum BioPharma (QNTM) Enlists Thermo Fisher's Clinical Research Business to Launch Phase 2 Lucid-MS Trial (NewMediaWire)
02:07AM	Loading…
Oct-05-26 02:07AM	JPMorgan Adds New Stocks to Its October Favorites List (BeInCrypto)
Sep-28-26 08:00AM	Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026 (Business Wire)
Sep-25-26 06:29PM	What Needs To Be True To Buy Twist Bioscience Stock Now? (Trefis)
Sep-24-26 06:34AM	Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher (InvestorsHub)
Sep-22-26 08:36AM	G2s CFO says SaaS expos may become obsolete (CFO.com)
Sep-21-26 07:00AM	Mayo Clinic, Thermo Fisher partner to create Precure (MedTech Dive)
Sep-17-26 10:11AM	Three Analysts, Three Verdicts on Thermo Fisher: Heres Who the Numbers Favor (TIKR)
Sep-16-26 04:41PM	Top Stock Reports for Cisco, Lam Research & Thermo Fisher (Zacks)
Sep-15-26 01:16PM	Thermo Fisher CEO Says AI Will Drive More Pharma Spending Sees 7% Organic Growth By 2028 (Stocktwits)
Sep-09-26 09:51AM	Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls (The Fly)
Sep-08-26 03:37PM	ILMN Stock Keeps Climbing. Should You Climb On? (Trefis)
Sep-01-26 08:00AM	Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026 (Business Wire)
Aug-31-26 09:00PM	Partners Group Private Equity Ltd (LSE:PEY) (Q2 2026) Earnings Call Highlights: Strong ... (GuruFocus.com)
Aug-25-26 03:30PM	Eli Lilly Is Pulling Away From the Rest of Healthcare (GuruFocus.com)
Aug-24-26 05:34PM	Top Research Reports for Amgen, Thermo Fisher & Pepsi (Zacks)
04:10AM	Loading…
04:10AM	There are six stocks that hedge funds and mutual funds are both overweight - and SpaceX is one (MarketWatch)
Aug-21-26 06:15AM	XPO names chief legal officer (Trucking Dive)
Aug-13-26 07:19AM	Thermo Fisher closes $1.1B sale of microbiology unit to PE firm (MedTech Dive)
Aug-12-26 08:00AM	Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg (Business Wire)
Aug-10-26 04:10AM	Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost (Reuters)
Jul-30-26 02:29PM	Avantor Stock Surged Because One Segment Stopped Shrinking (Trefis)
Jul-24-26 08:23AM	Reading Between The Lines Of DHR's Latest Call (Trefis)
07:25AM	Thermo Fisher raises 2026 outlook after 10% growth in Q2 (Medical Device Network)
Jul-23-26 05:02PM	Thermo Fisher Scientific Inc (TMO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) +8.71%
04:30PM	Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market (MarketWatch)
09:47AM	The 'Standout Performance' That Could Save Thermo Fisher, Danaher And Others (Investor's Business Daily)
08:49AM	Thermo Fisher beats second-quarter expectations as customer demand strengthens (NYSE:TMO) (InvestorsHub)
06:38AM	Thermo Fisher stock rises 3% on second quarter earnings beat (Investing.com)
06:09AM	Thermo Fisher: Q2 Earnings Snapshot (Associated Press)
06:00AM	Thermo Fisher Scientific Reports Second Quarter 2026 Results (Business Wire)
05:35AM	Intel headlines Thursday's earnings slate (MarketWatch)
Jul-22-26 04:15AM	Seeing Machines, Frontier IP, ImmuPharma, MP Evans, Ariana Resources, 88 Energy - Small Cap Snapshot (Proactive)
Jul-17-26 06:56PM	Abbott Just Showed Its Growth Engine Has More Than One Cylinder (Trefis)
08:17AM	Can Abbott Stock Deliver on Its Second-Half Growth Promise? (Trefis)
Jul-13-26 04:50PM	Alamar Hits A High Note On Alzheimer's Buzz (Trefis)
Jul-09-26 05:00PM	Thermo Fisher Scientific Announces Quarterly Dividend (Business Wire)
Jul-06-26 06:00AM	Top 10 medtech deals in the first half of 2026 (MedTech Dive)
Jul-03-26 04:31AM	Thermo Fisher, Arcturus partner on Phase III ARCT-032 cystic fibrosis trial (Clinical Trials Arena)
Jul-01-26 08:00AM	Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026 (Business Wire)
Jun-26-26 11:51AM	Just How Far Could Corning Stock Swing From Here? (Trefis)
Jun-24-26 08:59AM	Buy Honeywell Stock Before The Split? (Trefis)
Jun-23-26 01:23PM	Nvidia Targets a $300 Billion Pharma Market (GuruFocus.com)
Jun-11-26 09:38AM	SpaceX initiated, Intel upgraded: Wall Street's top analyst calls (The Fly)
Jun-09-26 04:30PM	Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market (MarketWatch) +5.20%
Jun-03-26 09:55AM	Yum! Brands upgraded, Chipotle downgraded: Wall Street's top analyst calls (The Fly)
May-28-26 04:30PM	Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market (MarketWatch) +6.80%
08:00AM	Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies (Business Wire)
May-20-26 05:00PM	Thermo Fisher Scientific Announces Quarterly Dividend (Business Wire)
08:30AM	Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day (Business Wire)
May-19-26 10:47AM	Amazon, McDonald Surge Into Jefferies Top Picks Broadcom as Gets Cut (GuruFocus.com)
May-04-26 05:53PM	Agilent Technologies Names Michael Buckner as CLO (Exec Edge)
Apr-30-26 10:05AM	Is Corning Stock A Buy At 50 Times Earnings? (Trefis)
Apr-28-26 11:38AM	Thermo Fisher agrees to sell microbiology business to Astorg in $1bn deal (Medical Device Network)
08:00AM	Thermo Fisher Scientific to Host Investor Day (Business Wire)
07:00AM	Thermo Fisher inks $1.1B deal to sell microbiology unit to Astorg (MedTech Dive)
Apr-27-26 10:38AM	Thermo Fisher selling microbiology business to Astorg for $1.08B (Quartz)
09:09AM	Thermo Fisher to Sell Microbiology Business to Astorg (The Wall Street Journal)
08:00AM	Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg (Business Wire)
Apr-24-26 03:06AM	Thermo Fisher Scientific Inc (TMO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Apr-23-26 11:00AM	Thermo Fisher falls after earnings top estimates, but growth concerns persist (Proactive) -9.20%
08:10AM	Thermo Fisher dips in premarket despite Q1 earnings beat (InvestorsHub)
06:42AM	Thermo Fisher slips in premarket despite beating Q1 forecasts (Investing.com)
06:11AM	Thermo Fisher: Q1 Earnings Snapshot (Associated Press)
06:00AM	Thermo Fisher Scientific Reports First Quarter 2026 Results (Business Wire)
Apr-09-26 08:00AM	Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics (Business Wire)
Apr-01-26 08:00AM	Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026 (Business Wire)
Mar-25-26 08:21AM	Thermo Fisher Scientific acquires Clario for nearly $8.9bn (Clinical Trials Arena)
02:49AM	Thermo Fisher completes $8.9B buyout of Clario (MedTech Dive)
Mar-24-26 08:00AM	Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc. (Business Wire)
Mar-12-26 06:58AM	How Is Mettler-Toledo's Stock Performance Compared to Other Medical Devices Stocks? (Barchart)
Mar-10-26 11:11AM	Is Agilent Technologies Stock Underperforming the S&P 500? (Barchart)
05:38AM	Thermo Fisher Scientific Inc. (TMO) Announces the Opening of Cryo-Electron Microscopy Drug Discovery Center in South San Francisco (Insider Monkey)
Mar-08-26 07:59AM	Thermo Fisher Scientific Inc. (TMO) Launches New Color-Based Culture Media for Faster Detection of Candida Infections (Insider Monkey)
Mar-06-26 08:22AM	Is This the Right Time to Hold Thermo Fisher Stock in Your Portfolio? (Zacks)
Mar-03-26 10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Feb-28-26 02:41PM	Second HeLa Lawsuit Resolved As Novartis Reaches Confidential Settlement (Benzinga)
Feb-26-26 11:53PM	Here's What Analysts Think About Thermo Fisher Scientific (TMO) Post Earnings (Insider Monkey)
Feb-25-26 09:08PM	Why Analysts Are Closely Watching Thermo Fisher Scientific Inc. (TMO) (Insider Monkey)
04:15PM	Thermo Fisher Scientific Increases Quarterly Dividend (Business Wire)
10:25AM	How Is Thermo Fisher Scientifics Stock Performance Compared to Other Medical Devices Stocks? (Barchart)
Feb-24-26 02:30PM	Thermo Fisher Scientific Inc. (TMO) Carries a Mid-Single Digit Organic Growth Forecast (Insider Monkey)
11:47AM	Henry Schein Q4 Earnings Call Highlights (MarketBeat)
08:00AM	Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference (Business Wire)
Feb-18-26 02:28AM	Daniel Loeb's Third Point Loads Up On Chipotle, Constellation, Alibaba While Slashing TSM, Amazon in Q4 Shake-Up (Benzinga)
Feb-11-26 10:23AM	Thermo Fisher Scientific Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Britt Lisa P.	Officer	Oct 28 '26	Proposed Sale	706.45	2,831	1,999,960		Oct 28 04:45 PM
Pettiti Gianluca	President & COO	Aug 31 '26	Option Exercise	309.63	3,733	1,155,849	26,949	Sep 01 04:10 PM
Pettiti Gianluca	President & COO	Aug 31 '26	Sale	614.38	4,133	2,539,233	23,216	Sep 01 04:10 PM
Pettiti Gianluca	Officer	Aug 31 '26	Proposed Sale	614.38	4,133	2,539,233		Aug 31 11:37 AM
CASPER MARC N	Chairman & CEO	Aug 24 '26	Option Exercise	309.63	275	85,148	124,200	Aug 26 04:01 PM
CASPER MARC N	Chairman & CEO	Aug 24 '26	Sale	627.05	275	172,439	123,925	Aug 26 04:01 PM
CASPER MARC N	Officer	Aug 24 '26	Proposed Sale	627.05	275	172,438		Aug 24 04:29 PM
CASPER MARC N	Chairman & CEO	Aug 20 '26	Option Exercise	309.63	10,000	3,096,300	133,925	Aug 24 04:02 PM
CASPER MARC N	Chairman & CEO	Aug 21 '26	Option Exercise	309.63	10,000	3,096,300	133,925	Aug 24 04:02 PM
CASPER MARC N	Chairman & CEO	Aug 20 '26	Sale	629.27	10,000	6,292,670	123,925	Aug 24 04:02 PM
CASPER MARC N	Chairman & CEO	Aug 21 '26	Sale	626.92	10,000	6,269,153	123,925	Aug 24 04:02 PM
CASPER MARC N	Officer	Aug 21 '26	Proposed Sale	626.91	10,000	6,269,123		Aug 21 04:40 PM
CASPER MARC N	Officer	Aug 20 '26	Proposed Sale	629.27	10,000	6,292,653		Aug 20 04:33 PM
Britt Lisa P.	Sr. VP and Chief HR Officer	Aug 19 '26	Option Exercise	418.32	11,440	4,785,581	26,224	Aug 20 04:02 PM
Britt Lisa P.	Sr. VP and Chief HR Officer	Aug 19 '26	Sale	613.12	11,440	7,014,093	14,784	Aug 20 04:02 PM
Britt Lisa P.	Officer	Aug 19 '26	Proposed Sale	613.12	11,440	7,014,110		Aug 19 01:44 PM
Shafer Michael D	Executive Vice President	Aug 11 '26	Option Exercise	370.58	25,500	9,449,832	35,294	Aug 13 04:01 PM
Shafer Michael D	Executive Vice President	Aug 11 '26	Sale	600.00	25,500	15,300,000	20,994	Aug 13 04:01 PM
Shafer Michael D	Officer	Aug 11 '26	Proposed Sale	600.00	25,500	15,300,000		Aug 11 12:22 PM
Holmes Joseph R.	VP & Chief Accounting Officer	Aug 07 '26	Option Exercise	309.63	420	130,045	3,386	Aug 10 04:09 PM
Holmes Joseph R.	VP & Chief Accounting Officer	Aug 07 '26	Sale	584.81	420	245,620	2,966	Aug 10 04:09 PM
CASPER MARC N	Chairman & CEO	Aug 07 '26	Option Exercise	309.63	275	85,148	124,200	Aug 10 04:09 PM
CASPER MARC N	Chairman & CEO	Aug 07 '26	Sale	586.12	4,608	2,700,823	0	Aug 10 04:09 PM
CASPER MARC N	Chairman & CEO	Aug 07 '26	Sale	586.10	275	161,179	123,925	Aug 10 04:09 PM
Britt Lisa P.	Sr. VP and Chief HR Officer	Aug 06 '26	Option Exercise	309.63	5,850	1,811,336	20,634	Aug 07 05:32 PM
Britt Lisa P.	Sr. VP and Chief HR Officer	Aug 06 '26	Sale	580.00	5,850	3,393,000	14,784	Aug 07 05:32 PM
CASPER MARC N	Chairman & CEO	Aug 06 '26	Option Exercise	309.63	10,000	3,096,300	133,925	Aug 07 05:26 PM
CASPER MARC N	Chairman & CEO	Aug 06 '26	Sale	574.47	10,000	5,744,695	123,925	Aug 07 05:26 PM
CASPER MARC N	Chairman & CEO	Aug 06 '26	Sale	574.45	5,000	2,872,272	4,608	Aug 07 05:26 PM
CASPER MARC N	Chairman & CEO	Aug 05 '26	Option Exercise	309.63	10,000	3,096,300	133,925	Aug 07 05:26 PM
CASPER MARC N	Chairman & CEO	Aug 05 '26	Sale	575.23	10,000	5,752,282	123,925	Aug 07 05:26 PM
CASPER MARC N	Chairman & CEO	Aug 05 '26	Sale	575.23	5,000	2,876,152	9,608	Aug 07 05:26 PM
Holmes Joseph R.	Officer	Aug 07 '26	Proposed Sale	584.81	420	245,621		Aug 07 03:59 PM
CASPER MARC N	Officer	Aug 07 '26	Proposed Sale	578.00	4,883	2,822,374		Aug 07 12:48 PM
Britt Lisa P.	Officer	Aug 06 '26	Proposed Sale	580.00	5,850	3,393,000		Aug 06 04:53 PM
CASPER MARC N	Officer	Aug 06 '26	Proposed Sale	576.80	15,000	8,652,000		Aug 06 02:43 PM
CASPER MARC N	Officer	Aug 05 '26	Proposed Sale	567.93	15,000	8,518,950		Aug 05 12:07 PM
Pettiti Gianluca	President & COO	Jul 27 '26	Sale	565.00	400	226,000	24,651	Jul 28 04:24 PM
Pettiti Gianluca	Officer	Jul 27 '26	Proposed Sale	565.00	400	226,000		Jul 27 10:04 AM
Lagarde Michel	Former Officer	May 29 '26	Proposed Sale	488.67	45,940	22,449,371		May 29 12:14 PM
Lowery Frederick M.	Former Officer	May 27 '26	Proposed Sale	452.14	14,300	6,465,589		May 27 11:41 AM
Pettiti Gianluca	President & COO	Apr 27 '26	Sale	462.66	400	185,064	25,051	Apr 29 04:38 PM
Pettiti Gianluca	Officer	Apr 27 '26	Proposed Sale	462.66	400	185,064		Apr 27 09:58 AM
Shafer Michael D	Executive Vice President	Mar 11 '26	Sale	499.40	1,607	802,536	20,950	Mar 12 04:23 PM
Shafer Michael D	Officer	Mar 11 '26	Proposed Sale	499.40	1,607	802,536		Mar 11 10:28 AM
CASPER MARC N	Chairman & CEO	Mar 05 '26	Option Exercise	309.63	4,000	1,238,520	127,925	Mar 09 04:39 PM
CASPER MARC N	Chairman & CEO	Mar 05 '26	Sale	514.82	4,000	2,059,261	123,925	Mar 09 04:39 PM
CASPER MARC N	Chairman & CEO	Mar 03 '26	Option Exercise	309.63	5,000	1,548,150	128,925	Mar 05 04:53 PM
CASPER MARC N	Chairman & CEO	Mar 04 '26	Option Exercise	309.63	5,000	1,548,150	128,925	Mar 05 04:53 PM
CASPER MARC N	Chairman & CEO	Mar 04 '26	Sale	512.40	5,000	2,561,994	123,925	Mar 05 04:53 PM
CASPER MARC N	Chairman & CEO	Mar 03 '26	Sale	503.10	5,000	2,515,495	123,925	Mar 05 04:53 PM
CASPER MARC N	Officer	Mar 05 '26	Proposed Sale	503.18	4,000	2,012,720		Mar 05 10:19 AM
CASPER MARC N	Officer	Mar 04 '26	Proposed Sale	510.00	5,000	2,550,000		Mar 04 10:25 AM
CASPER MARC N	Officer	Mar 03 '26	Proposed Sale	501.51	5,000	2,507,550		Mar 03 12:23 PM
Williamson Stephen	Officer	Mar 03 '26	Proposed Sale	498.92	6,000	2,993,520		Mar 03 10:43 AM
Pettiti Gianluca	Executive Vice President	Feb 09 '26	Sale	541.20	400	216,480	20,752	Feb 11 04:26 PM
Pettiti Gianluca	Officer	Feb 09 '26	Proposed Sale	541.20	400	216,480		Feb 09 10:18 AM
Lagarde Michel	Executive Vice President & COO	Dec 04 '25	Option Exercise	120.07	40,683	4,884,676	106,163	Dec 05 04:40 PM
Lagarde Michel	Executive Vice President & COO	Dec 04 '25	Sale	563.56	22,046	12,424,244	84,117	Dec 05 04:40 PM
Lagarde Michel	Executive Vice President & COO	Dec 03 '25	Option Exercise	105.17	68,000	7,151,560	97,480	Dec 04 04:46 PM
Lagarde Michel	Executive Vice President & COO	Dec 02 '25	Option Exercise	105.17	36,000	3,786,120	59,480	Dec 04 04:46 PM
Lagarde Michel	Executive Vice President & COO	Dec 03 '25	Sale	583.39	32,000	18,668,526	65,480	Dec 04 04:46 PM
Lagarde Michel	Executive Vice President & COO	Dec 02 '25	Sale	581.92	30,000	17,457,600	29,480	Dec 04 04:46 PM
Lagarde Michel	Officer	Dec 04 '25	Proposed Sale	563.56	22,046	12,424,321		Dec 04 11:03 AM
Lowery Frederick M.	Executive Vice President	Dec 01 '25	Option Exercise	253.99	6,913	1,755,833	21,280	Dec 03 04:48 PM
Lowery Frederick M.	Executive Vice President	Dec 02 '25	Option Exercise	253.99	6,912	1,755,579	21,279	Dec 03 04:48 PM
Lowery Frederick M.	Executive Vice President	Dec 01 '25	Sale	597.68	6,913	4,131,762	14,367	Dec 03 04:48 PM
Lowery Frederick M.	Executive Vice President	Dec 02 '25	Sale	581.94	6,912	4,022,369	14,367	Dec 03 04:48 PM
Lagarde Michel	Officer	Dec 03 '25	Proposed Sale	583.39	32,000	18,668,515		Dec 03 03:53 PM
Lagarde Michel	Officer	Dec 02 '25	Proposed Sale	581.92	30,000	17,457,611		Dec 02 03:29 PM
Lowery Frederick M.	Officer	Dec 02 '25	Proposed Sale	581.94	6,912	4,022,369		Dec 02 10:00 AM
Lowery Frederick M.	Officer	Dec 01 '25	Proposed Sale	597.68	6,913	4,131,762		Dec 01 10:37 AM
Shafer Michael D	Executive Vice President	Nov 25 '25	Option Exercise	262.39	10,725	2,814,110	27,206	Nov 26 05:24 PM
Shafer Michael D	Executive Vice President	Nov 25 '25	Sale	600.00	10,725	6,435,000	18,731	Nov 26 05:24 PM
Shafer Michael D	Officer	Nov 25 '25	Proposed Sale	600.00	10,725	6,435,000		Nov 25 02:29 PM
Britt Lisa P.	Sr. VP and Chief HR Officer	Nov 12 '25	Sale	588.26	1,058	622,136	13,087	Nov 14 04:51 PM
Lagarde Michel	Executive Vice President & COO	Nov 13 '25	Option Exercise	253.99	4,638	1,178,006	28,118	Nov 14 04:47 PM
Lagarde Michel	Executive Vice President & COO	Nov 13 '25	Sale	594.42	4,638	2,756,920	23,480	Nov 14 04:47 PM
Lagarde Michel	Officer	Nov 13 '25	Proposed Sale	594.42	4,638	2,756,935		Nov 13 11:46 AM
Britt Lisa P.	Officer	Nov 12 '25	Proposed Sale	588.03	1,058	622,136		Nov 12 05:06 PM
Pettiti Gianluca	Executive Vice President	Nov 10 '25	Option Exercise	284.26	2,975	845,688	23,402	Nov 12 04:36 PM
Pettiti Gianluca	Executive Vice President	Nov 10 '25	Sale	580.00	2,975	1,725,500	21,152	Nov 12 04:36 PM
Britt Lisa P.	Sr. VP and Chief HR Officer	Nov 07 '25	Option Exercise	253.99	8,475	2,152,565	22,620	Nov 10 04:51 PM
Britt Lisa P.	Sr. VP and Chief HR Officer	Nov 07 '25	Sale	571.62	10,225	5,844,850	14,145	Nov 10 04:51 PM
Pettiti Gianluca	Officer	Nov 10 '25	Proposed Sale	580.00	2,975	1,725,500		Nov 10 10:30 AM
Britt Lisa P.	Officer	Nov 07 '25	Proposed Sale	571.62	10,225	5,844,850		Nov 07 05:13 PM

Thermo Fisher Scientific Inc. offers products and services to customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of disease. The Analytical Instruments segment offers instruments and supporting consumables, software and services. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments and associated products to healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers outsourced services used by the pharmaceutical and biotech industries for drug development, clinical research, clinical trials services and commercial drug manufacturing. The company was founded in July 1956 and is headquartered in Waltham, MA.

Chairman & CEOMr. Marc N. Casper

PresidentMr. Gianluca Pettiti

Senior VP & CFOMr. James R. Meyer

VP & Chief Accounting OfficerMr. Joseph R. Holmes

Senior VP & Chief Information OfficerMr. Ryan J. Snyder

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TMO

Thermo Fisher Scientific Inc

Upgrade your Finviz experience